Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/24853
Title: | May Measurement Month 2018: an analysis of blood pressure screening results from Australia. | Austin Authors: | Carnagarin, Revathy;Fonseca, Ricardo;Brockman, Derrin;Critchley, Sue;Tan, Isabella;Trengove, Naomi;Tan, Kearney;Lambert, Gavin W;Cowley, Diane;Burrell, Louise M ;Poulter, Neil R;Beaney, Thomas;Ster, Anca Chis;Xia, Xin;Schlaich, Markus P | Affiliation: | Neurovascular Hypertension & Kidney Disease Laboratory, Alfred & Baker Hypertension Network, Baker Heart and Diabetes Institute, Melbourne, Australia Imperial Clinical Trials Unit, Imperial College London, UK Medicine (University of Melbourne) Princess Alexandra Hospital (Queensland Health), Brisbane, Australia Swinburne University of Technology, Melbourne, Australia Notre Dame University, Perth, Australia Macquarie University, Sydney, Australia Department of Nephrology, Royal Perth Hospital, Perth, Australia Department of Cardiology, Royal Perth Hospital, Perth, Australia Department of Primary Care and Public Health, Imperial College London.. Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth, WA, 6000, Australia Curtin University, Perth, Australia Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia |
Issue Date: | Aug-2020 | Date: | 2020 | Publication information: | European Heart Journal Supplements 2020; 22(Suppl H): H17-H19 | Abstract: | May Measurement Month (MMM), originally initiated as a temporary solution to address the lack of blood pressure (BP) screening programs worldwide, emerged as an effective annual campaign to increase the awareness of hypertension. MMM18, a cross-sectional survey of volunteers aged ≥18 years was carried out during May 2018 predominantly in capital cities across Australia following the standard MMM protocol. Blood pressure screening along with additional information including anthropometric data and responses to questionnaires on demographic, lifestyle, and environmental factors were collected from 3 352 individuals across Australia. After multiple imputation, 1 026 (30.6%) adult Australians had hypertension. Of the 2 936 individuals not on antihypertensive treatment, 610 (20.8%) were hypertensive, and 237 (57.1%) of the 416 individuals receiving antihypertensive treatment had uncontrolled BP. In line with MMM17 results and other previous surveys, MMM18 revealed that close to one-third of the screened population (30.6%) had hypertension, 57.1% of individuals treated with BP-lowering medication remained uncontrolled indicating suboptimal management of the condition in the majority of patients. Most importantly, only 49.0% of those with hypertension were aware of their elevated BP, highlighting lack of awareness of elevated BP in nearly half of the affected population. Elevated BP was directly associated with alcohol consumption, overweight, and obesity. Our findings demonstrate the need for (i) continued efforts to increase BP awareness in the population, (ii) optimization of BP management strategies, and (iii) tackling some of the major contributors to BP elevation, including alcohol consumption and obesity. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/24853 | DOI: | 10.1093/eurheartj/suaa018 | Journal: | European Heart Journal Supplements | PubMed URL: | 32884459 | ISSN: | 1520-765X | Type: | Journal Article | Subjects: | Awareness Blood pressure Control Hypertension Screening Treatment |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.